Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasisAndrea Di Giorgio, Stefano Rotolo, Bruno Romanò et al.|Surgical Oncology|2020Cited by 59
The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO StudyMaurizio Muscaritoli, Stefania Gori, Alessandra Modena et al.|Cancers|2023Cited by 27
Bidirectional Systemic Chemotherapy and Pressurized Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis from Gastric CancerAndrea Di Giorgio, Fabio Pacelli, Stefano Rotolo et al.|European Journal of Surgical Oncology|2020Cited by 3
Phase II randomized study of maintenance therapy with regorafenib (REGO) versus placebo after first-line platinum and fluoropyrimidines-based chemotherapy in HER2 negative locally advanced/metastatic gastric (GC) or gastroesophageal junction (GEJ) cancer: Results of a-MANTRA study (GOIRC-05-2016).Angela Damato, Carmine Pinto, Domenico Bilancia et al.|Journal of Clinical Oncology|2024Cited by 1